The Importance of Liver Density on CT Scan in Heart Failure Patients

Introduction Heart failure (HF) is a major global health problem associated with substantial morbidity and mortality. Hepatic involvement is common in HF and may reflect the severity of systemic congestion and impaired hemodynamics. Although liver function tests and bilirubin levels have been investigated as prognostic markers in HF, the clinical significance of liver density measured by computed tomography (CT) has received less attention. This study aimed to evaluate the association between liver density on CT scans and clinical, laboratory, echocardiographic, and prognostic parameters in patients with HF. Methods This retrospective cross-sectional study included 145 patients with HF admitted to a tertiary heart center between 2020 and 2022. Adults with HF with reduced or mid-range ejection fraction confirmed by echocardiography were included. Demographic, clinical, laboratory, chest CT, and echocardiographic data were obtained from medical records. Statistical analyses were performed using SPSS version 24.0. Continuous variables were expressed as mean ± standard deviation and categorical variables as frequencies. Associations were assessed using independent t-tests and chi-square tests. A p-value < 0.05 was considered statistically significant. Results The mean age was 42.8 ± 10.5 years, and the mean BMI was 27.06 ± 4.44 kg/m². Most patients were male. Edema and ascites were positively associated with liver density, whereas LVEDD (r = − 0.32) and SPAP (r = − 0.276) showed significant negative correlations. No significant association was observed between liver density and TAPSE (r = 0.056). Electrolytes, creatinine, and liver function tests were also associated with liver density. Patients with cardiac-related mortality had a mean liver density of 47.29 ± 7.1 HU, and this association was statistically significant (P = 0.029). Conclusion Liver density measured on chest CT may provide useful prognostic information in patients with HF and could serve as an additional imaging marker for clinical risk assessment.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-18
DOI
https://doi.org/10.21203/rs.3.rs-11210516/v1
Primary Topic
Heart Failure Treatment and Management
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

The Importance of Liver Density on CT Scan in Heart Failure Patients

Sepideh Taghavi, Razieh Omidvar, Hamidreza Pouraliakbar, Marzieh Mirtajaddini et al.
2 links
Research Square
Heart Failure Treatment and Management
preprint

The Importance of Liver Density on CT Scan in Heart Failure Patients

Sepideh Taghavi, Razieh Omidvar, Hamidreza Pouraliakbar, Marzieh Mirtajaddini, Parvin Goli, Hoda Gharoy, Arezo Hafezi Birgani, Nasim Naderi, Mahdi Saadat
preprint en

Abstract

Introduction Heart failure (HF) is a major global health problem associated with substantial morbidity and mortality. Hepatic involvement is common in HF and may reflect the severity of systemic congestion and impaired hemodynamics. Although liver function tests and bilirubin levels have been investigated as prognostic markers in HF, the clinical significance of liver density measured by computed tomography (CT) has received less attention. This study aimed to evaluate the association between liver density on CT scans and clinical, laboratory, echocardiographic, and prognostic parameters in patients with HF. Methods This retrospective cross-sectional study included 145 patients with HF admitted to a tertiary heart center between 2020 and 2022. Adults with HF with reduced or mid-range ejection fraction confirmed by echocardiography were included. Demographic, clinical, laboratory, chest CT, and echocardiographic data were obtained from medical records. Statistical analyses were performed using SPSS version 24.0. Continuous variables were expressed as mean ± standard deviation and categorical variables as frequencies. Associations were assessed using independent t-tests and chi-square tests. A p-value < 0.05 was considered statistically significant. Results The mean age was 42.8 ± 10.5 years, and the mean BMI was 27.06 ± 4.44 kg/m². Most patients were male. Edema and ascites were positively associated with liver density, whereas LVEDD (r = − 0.32) and SPAP (r = − 0.276) showed significant negative correlations. No significant association was observed between liver density and TAPSE (r = 0.056). Electrolytes, creatinine, and liver function tests were also associated with liver density. Patients with cardiac-related mortality had a mean liver density of 47.29 ± 7.1 HU, and this association was statistically significant (P = 0.029). Conclusion Liver density measured on chest CT may provide useful prognostic information in patients with HF and could serve as an additional imaging marker for clinical risk assessment.

Research Square
Iran University of Medical Sciences (IR)
Good health and well-being
Heart Failure Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon